PMC:7102591 / 10904-11096 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"333","span":{"begin":166,"end":168},"obj":"Gene"},{"id":"339","span":{"begin":30,"end":38},"obj":"Species"},{"id":"340","span":{"begin":144,"end":152},"obj":"Species"},{"id":"349","span":{"begin":13,"end":23},"obj":"Disease"},{"id":"350","span":{"begin":27,"end":29},"obj":"Disease"},{"id":"351","span":{"begin":127,"end":137},"obj":"Disease"},{"id":"352","span":{"begin":141,"end":143},"obj":"Disease"}],"attributes":[{"id":"A333","pred":"tao:has_database_id","subj":"333","obj":"Gene:1431"},{"id":"A339","pred":"tao:has_database_id","subj":"339","obj":"Tax:9606"},{"id":"A340","pred":"tao:has_database_id","subj":"340","obj":"Tax:9606"},{"id":"A349","pred":"tao:has_database_id","subj":"349","obj":"MESH:D007239"},{"id":"A350","pred":"tao:has_database_id","subj":"350","obj":"MESH:D001172"},{"id":"A351","pred":"tao:has_database_id","subj":"351","obj":"MESH:D007239"},{"id":"A352","pred":"tao:has_database_id","subj":"352","obj":"MESH:D001172"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"gher risk of infections in RA patients [[39], [40], [41]], cohort and case-control studies reported increased rates of overall infections in RA patients treated with CS, according to a dose-de"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T52","span":{"begin":166,"end":168},"obj":"Body_part"}],"attributes":[{"id":"A52","pred":"fma_id","subj":"T52","obj":"http://purl.org/sig/ont/fma/fma284995"}],"text":"gher risk of infections in RA patients [[39], [40], [41]], cohort and case-control studies reported increased rates of overall infections in RA patients treated with CS, according to a dose-de"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T148","span":{"begin":13,"end":26},"obj":"Disease"},{"id":"T149","span":{"begin":27,"end":29},"obj":"Disease"},{"id":"T151","span":{"begin":127,"end":140},"obj":"Disease"},{"id":"T152","span":{"begin":141,"end":143},"obj":"Disease"}],"attributes":[{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A149","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0005272"},{"id":"A150","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A151","pred":"mondo_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A152","pred":"mondo_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/MONDO_0005272"},{"id":"A153","pred":"mondo_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"}],"text":"gher risk of infections in RA patients [[39], [40], [41]], cohort and case-control studies reported increased rates of overall infections in RA patients treated with CS, according to a dose-de"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T84","span":{"begin":53,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T85","span":{"begin":183,"end":184},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"gher risk of infections in RA patients [[39], [40], [41]], cohort and case-control studies reported increased rates of overall infections in RA patients treated with CS, according to a dose-de"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T80","span":{"begin":27,"end":29},"obj":"Chemical"},{"id":"T81","span":{"begin":141,"end":143},"obj":"Chemical"},{"id":"T82","span":{"begin":166,"end":168},"obj":"Chemical"}],"attributes":[{"id":"A80","pred":"chebi_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/CHEBI_73810"},{"id":"A81","pred":"chebi_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/CHEBI_73810"},{"id":"A82","pred":"chebi_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/CHEBI_73462"},{"id":"A83","pred":"chebi_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"gher risk of infections in RA patients [[39], [40], [41]], cohort and case-control studies reported increased rates of overall infections in RA patients treated with CS, according to a dose-de"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T54","span":{"begin":27,"end":29},"obj":"Phenotype"},{"id":"T55","span":{"begin":141,"end":143},"obj":"Phenotype"}],"attributes":[{"id":"A54","pred":"hp_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A55","pred":"hp_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/HP_0001370"}],"text":"gher risk of infections in RA patients [[39], [40], [41]], cohort and case-control studies reported increased rates of overall infections in RA patients treated with CS, according to a dose-de"}

{"project":"2_test","denotations":[{"id":"32205186-9251634-4826886","span":{"begin":41,"end":43},"obj":"9251634"},{"id":"32205186-22393128-4826887","span":{"begin":53,"end":55},"obj":"22393128"}],"text":"gher risk of infections in RA patients [[39], [40], [41]], cohort and case-control studies reported increased rates of overall infections in RA patients treated with CS, according to a dose-de"}